NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01134861,Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer,https://clinicaltrials.gov/study/NCT01134861,,COMPLETED,"RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and combining chemotherapy with radiation therapy may kill more tumor cells.

PURPOSE: Randomized phase III trial to compare the effectiveness of various schedules of radiation therapy and combination chemotherapy using vinblastine and cisplatin or cisplatin and etoposide in treating patients with stage II or stage III non-small cell lung cancer that cannot be removed surgically.",NO,Lung Cancer,DRUG: cisplatin|DRUG: Etoposide|DRUG: Vinblastine|RADIATION: Radiation therapy|DRUG: Cisplatin|RADIATION: Radiation therapy|RADIATION: Radiation therapy,"Overall Survival, from date of randomization to date of death or last follow-up for patients still alive",,,Radiation Therapy Oncology Group,National Cancer Institute (NCI)|NRG Oncology,ALL,"ADULT, OLDER_ADULT",PHASE3,610,NETWORK,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,RTOG-9410|U10CA021661|CDR0000063640,1994-07,1998-10,2012-03,2010-06-02,,2015-03-27,,
